Cargando…
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920472/ https://www.ncbi.nlm.nih.gov/pubmed/35301007 http://dx.doi.org/10.1016/j.kint.2022.03.005 |
_version_ | 1784669134936604672 |
---|---|
author | Cinkilic, Okan Anft, Moritz Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina |
author_facet | Cinkilic, Okan Anft, Moritz Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina |
author_sort | Cinkilic, Okan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8920472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89204722022-03-15 Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses Cinkilic, Okan Anft, Moritz Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-06 2022-03-14 /pmc/articles/PMC8920472/ /pubmed/35301007 http://dx.doi.org/10.1016/j.kint.2022.03.005 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Cinkilic, Okan Anft, Moritz Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title | Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title_full | Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title_fullStr | Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title_full_unstemmed | Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title_short | Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses |
title_sort | inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 sars-cov-2 vaccine doses compared with 4 doses |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920472/ https://www.ncbi.nlm.nih.gov/pubmed/35301007 http://dx.doi.org/10.1016/j.kint.2022.03.005 |
work_keys_str_mv | AT cinkilicokan inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT anftmoritz inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT blazqueznavarroarturo inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT meistertonil inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT rochtoralf inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT stervboulrik inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT pfaenderstephanie inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT westhofftimmh inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses AT babelnina inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses |